Tags

Type your tag names separated by a space and hit enter

Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
Clin Chem Lab Med. 2020 09 25; 58(10):e193-e196.CC

Authors+Show Affiliations

Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium. Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium. Qualiblood sa, Namur, Belgium.

Pub Type(s)

Letter

Language

eng

PubMed ID

32639942

Citation

Favresse, Julien, et al. "Response of anti-SARS-CoV-2 Total Antibodies to Nucleocapsid Antigen in COVID-19 Patients: a Longitudinal Study." Clinical Chemistry and Laboratory Medicine, vol. 58, no. 10, 2020, pp. e193-e196.
Favresse J, Eucher C, Elsen M, et al. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. Clin Chem Lab Med. 2020;58(10):e193-e196.
Favresse, J., Eucher, C., Elsen, M., Laffineur, K., Dogné, J. M., & Douxfils, J. (2020). Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. Clinical Chemistry and Laboratory Medicine, 58(10), e193-e196. https://doi.org/10.1515/cclm-2020-0962
Favresse J, et al. Response of anti-SARS-CoV-2 Total Antibodies to Nucleocapsid Antigen in COVID-19 Patients: a Longitudinal Study. Clin Chem Lab Med. 2020 09 25;58(10):e193-e196. PubMed PMID: 32639942.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. AU - Favresse,Julien, AU - Eucher,Christine, AU - Elsen,Marc, AU - Laffineur,Kim, AU - Dogné,Jean-Michel, AU - Douxfils,Jonathan, PY - 2020/06/22/received PY - 2020/06/23/accepted PY - 2020/7/9/pubmed PY - 2020/9/30/medline PY - 2020/7/9/entrez KW - COVID-19 KW - SARS-CoV-2 KW - kinetics KW - serology KW - symptom onset SP - e193 EP - e196 JF - Clinical chemistry and laboratory medicine JO - Clin Chem Lab Med VL - 58 IS - 10 SN - 1437-4331 UR - https://www.unboundmedicine.com/medline/citation/32639942/Response_of_anti_SARS_CoV_2_total_antibodies_to_nucleocapsid_antigen_in_COVID_19_patients:_a_longitudinal_study_ L2 - https://www.degruyter.com/document/doi/10.1515/cclm-2020-0962 DB - PRIME DP - Unbound Medicine ER -